Core Insights - Catheter Precision, Inc. announced that its LockeT suture retention device will be featured during live procedural cases at the International Symposium of Left Atrial Appendage 2026 conference, highlighting its significance in the cardiac electrophysiology market [1] Company Overview - Catheter Precision is a U.S.-based medical device company focused on developing innovative solutions for the treatment of cardiac arrhythmias, emphasizing collaboration with physicians and continuous product advancement [6] Product Information - The LockeT device is designed to assist in wound closure after percutaneous venous punctures, classified as a Class 1 device registered with the FDA and has received CE Mark approval [5] Event Participation - The ISLAA meeting serves as a multi-specialty cardiovascular educational symposium, where leading physicians will manage the program, providing hands-on demonstrations and product education for electrophysiology fellows [2][3] - Catheter Precision will participate in these sessions, allowing fellows to experience the LockeT device and learn about its benefits, including cost reduction for hospitals and same-day discharge [3] Industry Recognition - The CEO of Catheter Precision, David Jenkins, expressed pride in the growing recognition of LockeT at prestigious industry events, emphasizing the importance of live clinical cases for validating the device's efficiency and cost-effectiveness [4]
Catheter Precision's LockeT Suture Retention Device to be Featured in Live Cases at ISLAA 2026